Resveratrol interferes with N-nitrosodiethylamine-induced hepatocellular carcinoma at early and advanced stages in male Wistar rats

Molecular Medicine Reports

Volumn 4, Issue 6, 2011, Pages 1211-1217

  Rajasekaran, Devaraja ^a   Elavarasan, Jayasudha ^a   Sivalingam, Murugan ^a   Ganapathy, Ekambaram ^a   Kumar, Akhilandeeswari ^a   Kalpana, K ^a   Sakthisekaran, Dhanapal ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Apoptosis; Hepatocellular carcinoma; Resveratrol

Indexed keywords

ACID PHOSPHATASE; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; CASPASE 3; CYTOCHROME C; DIETHYLNITROSAMINE; LACTATE DEHYDROGENASE; POLY(ADENOSINE DIPHOSPHATE RIBOSE); PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; RESVERATROL;

ADVANCED CANCER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BODY MASS; CANCER THERAPY; CELL DIVISION; CHEMICAL ANALYSIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; EARLY CANCER; ENZYME ACTIVATION; HEPATOMEGALY; HISTOPATHOLOGY; IMMUNOBLOTTING; IN VIVO STUDY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER PARENCHYMA; LIVER STRUCTURE; MALE; NONHUMAN; OUTCOME ASSESSMENT; PROTEIN SECRETION; RAT; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; TISSUE SECTION; UPREGULATION;

ALPHA-FETOPROTEINS; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; CASPASE 3; CYTOCHROMES C; DIETHYLNITROSAMINE; LIVER NEOPLASMS; MALE; POLY(ADP-RIBOSE) POLYMERASES; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, WISTAR; STILBENES; TUMOR SUPPRESSOR PROTEIN P53;

RATTUS; RATTUS NORVEGICUS; VITACEAE;

EID: 80053121375     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2011.555     Document Type: Article

References (26)

1. Minguez B, Tovar V, Chiang D, Villanueva A and Llovet JM: Pathogenesis of hepatocellular carcinoma and molecular therapies. Curr Opin Gastroenterol 25: 186-194, 2009.
2. Bosch FX, Ribes J, Cleries R and Diaz M: Epidemiology of hepatocellular carcinoma. Clin Liver Dis 9: 191-211, 2005.
3. Bosch FX, Ribes J and Borras J: Epidemiology of primary liver cancer. Semin Liver Dis 19: 271-285, 1999. (Pubitemid 29488770)
4. Llovet JM, Ricci S, Mazzaferro V, et al: Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359: 378-390, 2008.
5. Cal C, Garban H, Jazirehi A, Yeh C, Mizutani Y and Bonavida B: Resveratrol and cancer: chemoprevention, apoptosis, and chemo-immunosensitizing activities. Curr Med Chem Anticancer Agents 3: 77-93, 2003. (Pubitemid 36221731)
6. Bishayee A, Politis T and Darvesh AS: Resveratrol in the chemoprevention and treatment of hepatocellular carcinoma. Cancer Treat Rev 36: 43-53, 2010.
7. Jang M, Cai L, Udeani GO, et al: Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275: 218-220, 1997. (Pubitemid 127696281)
8. Bishayee A, Darvesh AS, Politis T and McGory R: Resveratrol and liver disease: From bench to bedside and community. Liver Int 30: 1103-1114, 2010.
9. Bishayee A: Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials. Cancer Prev Res 2: 409-418, 2009.
10. Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S and Takada Y: Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res 24: 2783-2840, 2004. (Pubitemid 39409568)
11. Kweon S, Kim Y and Choi H: Grape extracts suppress the formation of preneoplastic foci and activity of fatty acid synthase in rat liver. Exp Mol Med 35: 371-378, 2003. (Pubitemid 37474469)
12. Bishayee A and Dhir N: Resveratrol-mediated chemoprevention of diethylnitrosamine-initiated hepatocarcinogenesis: inhibition of cell proliferation and induction of apoptosis. Chem Biol Interact 179: 131-144, 2009.
13. King J: Practical clinical enzymology. Van Nostrand, London, New York, p363, 1965.
14. Orlowski M and Meister A: Isolation of gamma-glutamyl transpeptidase from hog kidney. J Biol Chem 240: 338-347, 1965.
15. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ: Protein measurement with the folin phenol reagent. J Biol Chem 193: 265-275, 1951.
16. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
17. Guo W, Kong E and Meydani M: Dietary polyphenols, inflammation, and cancer. Nutr Cancer 61: 807-810, 2009.
18. Carbo N, Costelli P, Baccino FM, Lopez-Soriano FJ and Argiles JM: Resveratrol, a natural product present in wine, decreases tumour growth in a rat tumour model. Biochem Biophys Res Commun 254: 739-743, 1999. (Pubitemid 29290538)
19. Luther DJ, Ohanyan V, Shamhart PE, et al: Chemopreventive doses of resveratrol do not produce cardiotoxicity in a rodent model of hepatocellular carcinoma. Invest New Drugs 29: 380-391, 2011.
20. Sloane D, Chen H and Howell C: Racial disparity in primary hepatocellular carcinoma: tumor stage at presentation, surgical treatment and survival. J Natl Med Assoc 98: 1934-1939, 2006. (Pubitemid 44955937)
21. Delmas D, Jannin B, Cherkaoui Malki M and Latruffe N: Inhibitory effect of resveratrol on the proliferation of human and rat hepatic derived cell lines. Oncol Rep 7: 847-852, 2000.
22. Hsieh TC, Burfeind P, Laud K, Backer JM, Traganos F, Darzynkiewicz Z and Wu JM: Cell cycle effects and control of gene expression by resveratrol in human breast carcinoma cell lines with different metastatic potentials. Int J Oncol 15: 245-252, 1999.
23. Notas G, Nifli AP, Kampa M, Vercauteren J, Kouroumalis E and Castanas E: Resveratrol exerts its antiproliferative effect on HepG2 hepatocellular carcinoma cells, by inducing cell cycle arrest, and NOS activation. Biochim Biophys Acta 1760: 1657-1666, 2006.
24. Sun ZJ, Pan CE, Liu HS and Wang GJ: Anti-hepatoma activity of resveratrol in vitro. World J Gastroenterol 8: 79-81, 2002.
25. Michels G, Watjen W, Weber N, et al: Resveratrol induces apoptotic cell death in rat H4IIE hepatoma cells but necrosis in C6 glioma cells. Toxicology 225: 173-182, 2006. (Pubitemid 44108376)
26. Kuo PL, Chiang LC and Lin CC: Resveratrol-induced apoptosis is mediated by p53-dependent pathway in hep G2 cells. Life Sci 72: 23-34, 2002.